课题基金 / 基金详情

CIHR/GSK Chair of Diabetes: abnormal lipid metabolism in the development of type 2 diabetes

CIHR/GSK Chair of Diabetes: abnormal lipid metabolism in the development of type 2 diabetes
CIHR/GSK 糖尿病主席:2 型糖尿病发生过程中脂质代谢异常
批准号:
213439
负责人:
Carpentier Andr C
金额:
$27.32万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-09-01 至 2015-09-01

项目摘要

项目成果

Carpentier Andr C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 2 diabetes (adult onset diabetes) affects between 7 and 10 percent of the Canadian population and is a major cause of mortality and suffering from heart disease, stroke, amputations, blindness, and renal failure. Its prevalence in our country is inc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improved adipose tissue storage of dietary fatty acids as a new mechanism for the rapid remission of hepatic and cardiac metabolic dysfunction after bariatric surgery
  • 批准号:
    452242
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.66万
  • 财政年份:
    2021
  • 负责人:
    Carpentier Andr C
  • 依托单位:
The Right Timing to prevent Type 2 Diabetes: Restoring 24-hour substrate rhythmicity to improve glycemic control by timing of lifestyle factors
  • 批准号:
    424974
  • 项目类别:
    Operating Grants
  • 资助金额:
    $145.68万
  • 财政年份:
    2020
  • 负责人:
    Carpentier Andr C
  • 依托单位:
The Netherlands-Canada Type 2 Diabetes Research Consortium: The Right Timing to Prevent and Treat Type 2 Diabetes.
  • 批准号:
    415832
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2019
  • 负责人:
    Carpentier Andr C
  • 依托单位:
Canada Research Chair Tier 1
  • 批准号:
    392534
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2018
  • 负责人:
    Carpentier Andr C
  • 依托单位:
海外基金